CDX2 and prostate neoplasm: Our results, combined with the analysis of the TCGA data set, show that prostate tumours with Gleason pattern 4 share a common transcriptional regulatory programme defined by an enrichment of FOXA1, HOXB13 and CDX2 binding sites.